Naber KG - Search Results

1

[Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections?].

Naber KG, Alidjanov JF. Naber KG, et al. Urologiia. 2016 Aug;(3 Suppl 3):37-44. Urologiia. 2016. PMID: 28247617 Russian.

2

[Development and clinical testing of the Russian version of the Acute Cystitis Symptom Score - ACSS].

Alidjanov JF, Abdufattaev UA, Makhmudov DKh, Mirkhamidov DKh, Khadzhikhanov FA, Azgamov AV, Pilatz A, Naber KG, Wagenlehner FM, Akilov FA. Alidjanov JF, et al. Among authors: naber kg. Urologiia. 2014 Nov-Dec;(6):14-22. Urologiia. 2014. PMID: 25799721 Clinical Trial. Russian.

3

[German validation of the Acute Cystitis Symptom Score].

Alidjanov JF, Pilatz A, Abdufattaev UA, Wiltink J, Weidner W, Naber KG, Wagenlehner F. Alidjanov JF, et al. Among authors: naber kg. Urologe A. 2015 Sep;54(9):1269-76. doi: 10.1007/s00120-015-3873-5. Urologe A. 2015. PMID: 26113302 German.

4

[Therapy of the acute uncomplicated urinary tract infection].

Wagenlehner F, Hoyme U, Naber K. Wagenlehner F, et al. Urologe A. 2006 Apr;45(4):429-32, 434-5. doi: 10.1007/s00120-006-1022-x. Urologe A. 2006. PMID: 16534649 Review. German.

5

Prevention of recurrent urinary tract infections.

Wagenlehner FM, Vahlensieck W, Bauer HW, Weidner W, Piechota HJ, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Minerva Urol Nefrol. 2013 Mar;65(1):9-20. Minerva Urol Nefrol. 2013. PMID: 23538307 Review.

6

In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections.

Onda H, Wagenlehner FM, Lehn N, Naber KG. Onda H, et al. Among authors: naber kg. Int J Antimicrob Agents. 2001 Sep;18(3):263-6. doi: 10.1016/s0924-8579(01)00374-0. Int J Antimicrob Agents. 2001. PMID: 11673040

7

Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.

Naber KG, Llorens L, Kaniga K, Kotey P, Hedrich D, Redman R. Naber KG, et al. Antimicrob Agents Chemother. 2009 Sep;53(9):3782-92. doi: 10.1128/AAC.00837-08. Epub 2009 Jul 6. Antimicrob Agents Chemother. 2009. PMID: 19581455 Free PMC article. Clinical Trial.

8

Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.

Naber KG, Roscher K, Botto H, Schaefer V. Naber KG, et al. Int J Antimicrob Agents. 2008 Aug;32(2):145-53. doi: 10.1016/j.ijantimicag.2008.03.014. Epub 2008 Jun 20. Int J Antimicrob Agents. 2008. PMID: 18571904 Clinical Trial.

9

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.

Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D. Naber KG, et al. Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.

10

Survey on antibiotic usage in the treatment of urinary tract infections.

Naber KG. Naber KG. J Antimicrob Chemother. 2000 Sep;46 Suppl 1:49-52; discussion 63-5. J Antimicrob Chemother. 2000. PMID: 11051624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results